Commit To Purchase Keryx Biopharmaceuticals At $2.50, Earn 12% Using Options
July 24, 2018 at 11:53 AM EDT
Investors eyeing a purchase of Keryx Biopharmaceuticals Inc. (KERX) stock, but tentative about paying the going market price of $4.36/share, might benefit from considering selling puts among the alternative strategies at their disposal..